马来西亚医疗保健专业人员对药物基因组学知识和教育的需求和差距:一个多站点的Delphi研究
Safa Omran1, Siew Lian Leong1, Ali Blebil1
1School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.
Clinical and translational science
|November 11, 2024
概括
马来西亚的医疗保健专业人员报告说,在药物基因组学方面存在重大知识差距,这阻碍了其临床实施. 这项研究开发了一种量身定制的教育干预措施,以满足这些需求,并通过增强的药物基因组学实践改善患者的结果.
科学领域:
- 药物基因组学 药物基因组学
- 临床药房 临床药房
- 医学教育 医学教育
背景情况:
- 缺乏药物基因组学知识是其临床应用的主要障碍.
- 医疗保健专业人员报告说,尽管意识越来越大,但信心和知识很低.
- 实施药物基因组学需要解决现有的知识缺陷.
研究的目的:
- 评估马来西亚医疗保健专业人员的药物基因组学知识缺口和学习需求.
- 确定在临床实践中采用药物基因组学的障碍和促进因素.
- 为马来西亚医疗保健专业人员制定一个基于能力的教育干预措施.
主要方法:
- 一个经过修改的Delphi研究,涉及多学科专家小组.
- 在马来西亚的14个研究地点进行了有目的的抽样.
- 量化描述性统计分析,共识值为60%.
主要成果:
- 所有专家都认为建议的教育内容组件是必不可少的/重要的.
- 在药物基因组学采用的重大障碍和知识差距被确定.
- 开发了一个定制的,基于证据的教育干预措施.
结论:
- 德尔菲研究成功推动了针对性药物基因组学教育计划的创建.
- 为医疗保健专业人员提供药物基因组学能力对于改善患者健康结果至关重要.
- 需要进一步的研究来评估拟议的教育干预的可行性.
相关概念视频
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Nonlinear Pharmacokinetics: Overview
282
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
282
Nonlinear Pharmacokinetics: Role of Transporters
35
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
35
Factors Affecting Drug Biotransformation: Biological
116
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
116
Pharmacokinetic Models: Overview
592
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
592


